Failed Bush-era drug-pricing program may make more sense under Trump

A failed Bush-era program aimed at curbing the cost of doctor-administered drugs might actually work if the Trump administration has the political will to revive it, a number of independent drug experts agree. The Competitive Acquisition Program, which allows third parties to negotiate with manufacturers for drugs that physicians then buy, was among the ideas¬†included in President Donald Trump’s blueprint on lowering drug prices.

Faculty Associate Gerard Anderson is quoted.